FBT:NYE-First Trust NYSE Arca Biotechnology Index Fund (USD)

ETF | Health |

Last Closing

USD 152.75

Change

0.00 (0.00)%

Market Cap

N/A

Volume

0.03M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-06 )

ETFs Containing FBT

FBT:CA First Trust NYSE Arca Bio.. 99.83 % 0.00 %

N/A

CAD 1.83M
FHM:CA 0.00 % 0.78 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -8.10% 48% F 45% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -8.10% 48% F 44% F
Trailing 12 Months  
Capital Gain 1.11% 95% A 71% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.11% 95% A 57% F
Trailing 5 Years  
Capital Gain 13.69% 38% F 39% F
Dividend Return 1.65% 37% F 3% F
Total Return 15.33% 38% F 26% F
Average Annual (5 Year Horizon)  
Capital Gain 0.83% 38% F 38% F
Dividend Return 1.16% 38% F 28% F
Total Return 0.33% 42% F 9% A-
Risk Return Profile  
Volatility (Standard Deviation) 11.50% 81% B- 75% C
Risk Adjusted Return 10.09% 38% F 28% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.